{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:14:19Z","timestamp":1792512859945,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>This study investigates susceptibility toward three fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin), multiple fluoroquinolone-resistance mechanisms, and epidemiological relationship of neonatal septicaemic <jats:italic>Acinetobacter baumannii<\/jats:italic>. Previous studies on fluoroquinolone resistance in <jats:italic>A. baumannii<\/jats:italic> focused primarily on ciprofloxacin susceptibility and assessed a particular mechanism of resistance; a more holistic approach was taken here. Epidemiological relationship was evaluated by Multi Locus Sequence Typing. Minimum Inhibitory Concentrations of fluoroquinolones was determined with and without efflux pump inhibitors. Overexpression of efflux pumps, resistance-nodulation-cell-division (RND)-type, and multidrug and toxic compound extrusion (MATE)-type efflux pumps were evaluated by reverse transcriptase-qPCR. Mutations within regulatory proteins (AdeRS, AdeN, and AdeL) of RND-pumps were examined. Chromosomal mutations, presence of <jats:italic>qnr<\/jats:italic> and <jats:italic>aac(6<\/jats:italic>\u2032<jats:italic>)-Ib-cr<\/jats:italic> were investigated. <jats:italic>A. baumannii<\/jats:italic> were highly diverse as 24 sequence-types with seven novel STs (ST-1440\/ST-1441\/ST-1481\/ST-1482\/ST-1483\/ST-1484\/ST-1486) were identified among 47 <jats:italic>A. baumannii.<\/jats:italic> High resistance to ciprofloxacin (96%), levofloxacin (92%), and particularly moxifloxacin (90%) was observed, with multiple mechanisms being active. Resistance to 4<jats:sup>th<\/jats:sup> generation fluoroquinolone (moxifloxacin) in neonatal isolates is worrisome. Mutations within GyrA (S83L) and ParC (S80L) were detected in more than 90% of fluoroquinolone-resistant <jats:italic>A. baumannii<\/jats:italic> (FQRAB) spread across 10 different clonal complexes (CC1\/CC2\/CC10\/CC25\/CC32\/CC126\/CC149\/CC216\/CC218\/CC513). Efflux-based FQ resistance was found in 65% of FQRAB with \u22652 different active pumps in 38% of strains. Overexpression of <jats:italic>adeB<\/jats:italic> was highest (2.2\u221234-folds) followed by <jats:italic>adeJ<\/jats:italic>, <jats:italic>adeG<\/jats:italic>, and <jats:italic>abeM<\/jats:italic>. Amino acid changes in the regulators (AdeRS\/AdeN\/AdeL) either as single or multiple substitutions substantiated the overexpression of the pumps. Diverse mutations within AdeRS were detected among different CCs whereas mutations within AdeN linked to CC10 and CC32. Chromosomal mutations and active efflux pumps were detected simultaneously among 64% of FQRAB. Presence of <jats:italic>aac(6\u2032)-Ib-cr<\/jats:italic> was also high (74% of FQRAB) but <jats:italic>qnrS<\/jats:italic> were absent. As most FQRABs had chromosomal mutations, this was considered predominant, however, isolates where pumps were also active had higher MIC values, establishing the critical role of the efflux pumps. The high variability of FQ susceptibility among FQRAB, possessing the same set of mutations in <jats:italic>gyrA<\/jats:italic>, <jats:italic>parC<\/jats:italic>, and efflux pump regulators, was also noted. This reveals the complexity of interpreting the interplay of multiple resistance mechanisms in <jats:italic>A. baumannii<\/jats:italic>.<\/jats:p>","DOI":"10.3389\/fmicb.2021.602724","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T04:39:26Z","timestamp":1615437566000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Overexpression of Efflux Pumps, Mutations in the Pumps\u2019 Regulators, Chromosomal Mutations, and AAC(6\u2032)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Subhasree","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdatta","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulagna","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance.","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"B2","first-page":"623","article-title":"Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance.","volume":"18","author":"Ardebili","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3343\/alm.2014.34.6.433","article-title":"Correlation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates.","volume":"34","author":"Ardebili","year":"2014","journal-title":"Ann. Lab. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.","volume":"11","author":"Asif","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1128\/AAC.03535-14","article-title":"Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.","volume":"58","author":"Blanchard","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jac\/dkm204","article-title":"Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.","volume":"60","author":"Cattoir","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.micres.2015.11.010","article-title":"AdeR protein regulates adeABC expression by binding to a direct-repeat motif in the intercistronic spacer.","volume":"183","author":"Chang","year":"2016","journal-title":"Microbiol. Res."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01126","article-title":"Carbapenem resistance in Acinetobacter baumannii and other acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to ISAba125.","volume":"7","author":"Chatterjee","year":"2016","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijantimicag.2009.12.009","article-title":"Mechanisms of resistance to ciprofloxacin, ampicillin\/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.","volume":"35","author":"Chiu","year":"2010","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B10","year":"2019","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1128\/AAC.00155-10","article-title":"Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii.","volume":"54","author":"Coyne","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/AAC.00732-07","article-title":"AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.","volume":"52","author":"Damier-Piolle","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1128\/JB.184.23.6490","article-title":"Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of.","volume":"184","author":"Elkins","year":"2002","journal-title":"J. Bacteriol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204805","article-title":"Community level antibiotic utilization in India and its comparison vis-\u00e0-vis European countries: evidence from pharmaceutical sales data.","volume":"13","author":"Farooqui","year":"2018","journal-title":"PLoS One"},{"key":"B15","first-page":"179","article-title":"A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).","volume":"2","author":"Ferrara","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1186\/1757-4749-3-12","article-title":"Prevalence of aac(6\u2019)-Ib-cr plasmid-mediated and chromosome-encoded fluoroquinolone resistance in Enterobacteriaceae in Italy.","volume":"3","author":"Frasson","year":"2011","journal-title":"Gut. Pathog."},{"key":"B17","author":"Fuchs","year":"2016","journal-title":"Antibiotic Use for Sepsis in Neonates and Children: 2016 Evidence Update."},{"key":"B18","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1128\/AAC.49.8.3347-3354.2005","article-title":"Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.","volume":"49","author":"Ge","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/jac\/dky083","article-title":"Diversity of mutations in regulatory genes of resistance-nodulationcell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii.","volume":"73","author":"Gerson","year":"2018","journal-title":"J. Antimicrob.Chemother."},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-019-0537-z","article-title":"Control of Acinetobacter baumannii outbreak in the neonatal intensive care unit in latvia : whole-genome sequencing powered investigation and closure of the ward.","author":"Gramatniece","year":"2019"},{"key":"B21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jac\/dkh368","article-title":"Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin.","volume":"54","author":"Hamouda","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/jac\/dki397","article-title":"Development of highly ciprofloxacin-resistant laboratory mutants of Acinetobacterbaumannii lacking topoisomerase IV gene mutations.","volume":"57","author":"Hamouda","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1128\/AAC.44.8.2211-2213.2000","article-title":"Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.","volume":"44","author":"Heinemann","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.5897\/AJMR2013.5932","article-title":"Mutations in the quinolone resistance determining region in isogenic mutant Acinetobacter baumannii strains.","volume":"7","author":"Hongbo","year":"2013","journal-title":"AJMR"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance.","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00797-17","article-title":"Nosocomial outbreak of extensively drug-resistant Acinetobacter baumannii isolates containing bla OXA-237 carried on a plasmid.","volume":"61","author":"Hujer","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/JCM.02380-08","article-title":"Rapid determination of quinolone resistance in Acinetobacter spp.","volume":"47","author":"Hujer","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.diagmicrobio.2014.03.025","article-title":"Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan, China.","volume":"79","author":"Jiang","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-019-1439-1","article-title":"gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.","volume":"19","author":"Kivata","year":"2019","journal-title":"BMC Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001974","article-title":"Antibiotic resistance in india: drivers and opportunities for action.","volume":"13","author":"Laxminarayan","year":"2016","journal-title":"PLoS Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jmii.2011.09.001","article-title":"Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.","volume":"45","author":"Liu","year":"2012","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijantimicag.2012.08.012","article-title":"Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.","volume":"41","author":"Lopes","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B33","first-page":"162","article-title":"Detection of highly ciprofloxacin resistance.","volume":"9","author":"Maleki","year":"2014","journal-title":"MAEDICA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/AAC.48.9.3298","article-title":"Expression of the RND-type Ef ux Pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system.","volume":"48","author":"Marchand","year":"2004","journal-title":"Society"},{"key":"B35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1099\/jmm.0.000069","article-title":"Prevalence of eight resistance-nodulation-division efflux pump genes in epidemiologically characterized Acinetobacter baumannii of worldwide origin.","volume":"64","author":"Nowak","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.44.1.10-13.2000","article-title":"Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.","volume":"44","author":"Oethinger","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/jac\/dkl081","article-title":"Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-\u03b2-naphthylamide.","volume":"57","author":"Pannek","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1128\/AAC.00915-06","article-title":"Prevalence in the United States of aac(6\u2032)-Ib-cr encoding a ciprofloxacin-modifying enzyme.","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.phrp.2011.11.040","article-title":"Alterations of gyrA, gyrB, and parC and Activity of efflux pump in fluoroquinolone-resistant Acinetobacter baumannii.","volume":"2","author":"Park","year":"2011","journal-title":"Osong Public Heal. Res. Perspect."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9254907","article-title":"The first outbreak caused by Acinetobacter baumannii ST208 and ST195 in China.","volume":"2016","author":"Qu","year":"2016","journal-title":"Biomed Res. Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success.","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00430-16","article-title":"Regulates genes required for multidrug efflux, biofilm formation, and virulence in a strain-specific manner.","volume":"7","author":"Richmond","year":"2016","journal-title":"MBio"},{"key":"B43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","article-title":"Plasmid-mediated quinolone resistance: two decades on.","volume":"29","author":"Rodr\u00edguez-Mart\u00ednez","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10096-010-1030-z","article-title":"Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.","volume":"29","author":"Roy","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B46","author":"Rules","year":"2018","journal-title":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone Version 9.0."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1128\/AAC.00730-13","article-title":"Contribution of efflux pumps, porins, and \u03b2-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.","volume":"57","author":"Rumbo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/jac\/dkg424","article-title":"Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii.","volume":"52","author":"Spence","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1128\/AAC.49.10.4362","article-title":"AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters.","volume":"49","author":"Su","year":"2005","journal-title":"Society"},{"key":"B50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ja.2014.150","article-title":"Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.","volume":"68","author":"Sun","year":"2015","journal-title":"J. Antibiot."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/jac\/dkw002","article-title":"Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii.","volume":"71","author":"Sun","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.diagmicrobio.2007.10.002","article-title":"First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals.","volume":"60","author":"Touati","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1128\/JCM.00367-08","article-title":"Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.","volume":"46","author":"Valentine","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/jac\/49.3.471","article-title":"Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.","volume":"49","author":"Vila","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"B55","year":"2019","journal-title":"World Health Organization Model List of Essential Medicines, 21st List, 2019."},{"key":"B56","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1179\/1973947815y.0000000017","article-title":"Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China.","volume":"28","author":"Yang","year":"2015","journal-title":"J. Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1128\/aac.02556-12","article-title":"RND-Type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.","volume":"57","author":"Yoon","year":"2013","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.602724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T04:39:34Z","timestamp":1615437574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.602724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":57,"alternative-id":["10.3389\/fmicb.2021.602724"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.602724","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"602724"}}